SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-001123
Filing Date
2017-03-01
Accepted
2017-03-01 15:57:40
Documents
82
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2230923z10-k.htm 10-K 1532922
2 EX-12.1 a2230923zex-12_1.htm EX-12.1 28040
3 EX-23.1 a2230923zex-23_1.htm EX-23.1 5558
4 EX-31.1 a2230923zex-31_1.htm EX-31.1 8180
5 EX-31.2 a2230923zex-31_2.htm EX-31.2 8205
6 EX-32.1 a2230923zex-32_1.htm EX-32.1 4876
7 EX-32.2 a2230923zex-32_2.htm EX-32.2 4908
14 G255602.JPG g255602.jpg GRAPHIC 86305
  Complete submission text file 0001047469-17-001123.txt   8698821

Data Files

Seq Description Document Type Size
8 EX-101.INS gern-20161231.xml EX-101.INS 2279733
9 EX-101.SCH gern-20161231.xsd EX-101.SCH 61625
10 EX-101.CAL gern-20161231_cal.xml EX-101.CAL 55475
11 EX-101.DEF gern-20161231_def.xml EX-101.DEF 228431
12 EX-101.LAB gern-20161231_lab.xml EX-101.LAB 595622
13 EX-101.PRE gern-20161231_pre.xml EX-101.PRE 414621
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20859 | Film No.: 17653983
SIC: 2834 Pharmaceutical Preparations